Abstract-We evaluated the possible association between early vascular abnormalities and the metabolic syndrome (MS) in 77 normotensive subjects (mean age: 50 years) at risk of developing diabetes for family history of diabetes, obesity, or impaired fasting glucose. Fifty healthy subjects were recruited as controls. MS was defined according to the ATP III criteria. Brachial artery endothelium-dependent and -independent vasodilation were assessed as flow-mediated dilation (FMD) and response to glyceryl trinitrate (GTN, 25 g sublingual), respectively, by automatic computerized edge detection system. Carotid-femoral pulse wave velocity (PWV) and radial augmentation index (AIx) were assessed by applanation tonometry. PWV was significantly (PÏœ0.01) higher in subjects with MS (nÏ29, 9.0Ïź1.9 m/s) as compared with those without MS (nÏ48, 7.7Ïź1.2 m/s) and controls (7.2Ïź1.5 m/s). FMD was significantly (PÏœ0.05) reduced in both subjects with (5.8Ïź2.7%) and without MS (6.1Ïź3.7%) as compared with controls (6.9Ïź2.5%). No significant differences were found for response to GTN and AIx. PWV and FMD were significantly (PÏœ0.05) affected by increasing number of MS components. Among the components of the MS, only blood pressure significantly affected PWV, whereas blood pressure and fasting glucose influenced FMD. Logistic regression analysis showed that MS was associated with increased risk of altered PVW (odd ratio: 7.95, confidence limits: 1.06 to 69.11), whereas only blood pressure component was significantly related with increased risk of impaired FMD (odd ratio: 3.60, confidence limits: 1.01 to 12.78). In conclusion, in normotensive subjects at risk of developing diabetes mellitus, the presence of MS is associated with a selective alteration of central PWV. Key Words: arterial stiffness â
ą pulse wave velocity â
ą endothelium â
ą metabolic syndrome â
ą blood pressure M etabolic syndrome (MS), a clustering of cardiovascular risk factors, such as central obesity, insulin resistance, dyslipidemia, and hypertension, is associated with an increased risk of developing cardiovascular disease and diabetes mellitus. 1,2 Epidemiological studies suggest that MS per se might represent an independent predictor of cardiovascular morbidity and mortality. 3-5 MS has also been associated to early vascular alterations, such as increased arterial stiffness 6 -10 and endothelial dysfunction. [11][12][13] The association with these vascular alterations might account, at least in part, for the cardiovascular risk of patients with MS, 14 because both increased arterial stiffness 15 and endothelial dysfunction 16,17 have been demonstrated to be independent predictors of cardiovascular morbidity and mortality. Indeed, crosssectional studies have shown an association between MS and increased arterial stiffness in unselected populations. 6 -10 However, some of these studies might be biased by the presence in the study populations, beside other factors encompassing the MS, of overt hypertension or diabetes, 2 major and well characterized determinants of increas...